https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520GS%2520w%2520non%2520GAAP%25205_21_14.pdf
Use of Non-GAAP Measures
Page 3
PolyOne Commodity to Specialty Transformation
• Volume driven,
commodity producer
• Heavily tied to cyclical
end markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2014 2015 and beyond
• Steve Newlin
appointed, Chairman,
President and CEO
• New leadership team
appointed
• Implementation of
four pillar strategy
• Focus on value based
selling, investment in
commercial resources
and innovation to drive
transformation
• 18 consecutive
quarters of double-
digit adjusted EPS
growth
• Shift to faster growing,
high margin, less
cyclical end markets
• Key acquisitions propel
current and future
growth, as well as
margin expansion
• Established aggressive
2015 targets
• Continue specialty
transformation
• Targeting $2.50
Adjusted EPS by 2015,
nearly double 2013
EPS
• Drive double digit
operating income and
adjusted EPS growth
Page 4
2013 Revenues: $3.8 Billion
End Markets
2013 Revenues: $3.8 Billion
Page 5
PolyOne
At A Glance
United
States
67%
Europe
14%
Canada
7% Asia6%
Latin
America
6%
Specialty
54%
PP&S
18%
Distribution
28%
$13
$31
$46 $46
$92 $96
$122
$195
$0
$50
$100
$150
$200
2006 2007 2008 2009 2010 2011 2012 2013
Specialty Operating Income
Building &
Construction
13%
Industrial
12%
Transportation
18%
Wire & Cable
9%
Packaging
16%
Consumer
10%
HealthCare
11% Appliance
6%
Electronics &
Electrical
5%
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
2%
34% 43%
62% 64%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 Q1 2014 2015
%
o
f O
pe
ra
tin
g
In
co
m
e*
JV's Performance Products & Solutions Distribution Specialty
65-75%
Specialty OI $5M $46M $87M $195M $60M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 6
Confirmation of Our Strategy
The World’s Premier Provider of Specialized
Polymer Materials, Services and Solutions
Specialization Globalization
Operational
Excellence
Commercial
Excellence
Page 7
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
450.00%
550.00%
PolyOne S&P 500
Strategy and Execution Drive Results
$0.12
$0.27
$0.21
$0.13
$0.68
$0.82
$1.00
$1.31
'06 '07 '08 '09 '10 '11 '12 '13
‘06-‘13 EPS CAGR = 41%
EPS Share Price vs.
S&P 500
All time high of
$39.55
May 13th, 2014
Page 8
2006 Q1 2014 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 13.8% 12 – 16%
Global Specialty Engineered
Materials 1.1% 11.6% 12 – 16%
Designed Structures & Solutions -- 6.5% 8 – 10%
Performance Products &
Solutions 5.5% 7.7% 9 – 12%
Distribution 2.6% 6.1% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 64% 65 – 75%
3) ROIC* 5.0% 9.4% 15%
4) Adjusted EPS Growth N/A 42% Double Digit Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 9
Bridge to $2.50 Adjusted EPS by 2015
2015 EPS: $2.50
2013 EPS: $1.31
Continued Gross Margin
Expansion
Mergers & Acquisitions
Spartech Accretion
Incremental share buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation
& Mix Improvement Several Levers to
Drive Growth
Mid single digit revenue CAGR
Page 10
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
Page 11
$20
$53
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14.3%
30.7%
2006 2013
Specialty Platform
Gross Margin %
19.5%
43.0%
2006 2013
Healthcare
Consumer
Packaging and Additive Technology
Transportation
Page 12
Unique and Innovative Solutions
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2014
Pension Funding**
As of March 31, 2014
Debt Maturities & Pension Funding – 3/31/14
Net Debt / EBITDA* = 1.9x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2014
($ millions)
Coupon Rates: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 3/31/2014
Page 13
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
$0.16
$0.20
$0.24
$0.32
$0.10
$0.20
$0.30
$0.40
2011 2012 2013 2014
Annual Dividend
Expanding our sales, marketing, and
technical capabilities
Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
Synergy opportunities
Adjacent material solutions
Repurchased 1.4 million shares in Q1
2014
Repurchased 6.4 million shares
since April 2013
13.6 million shares are
available for repurchase
under the current
authorization
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
Investing in operational and
LSS initiatives (including
synergy capture)
Manufacturing alignment
Page 14
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2024-07/CCG Application Snapshot Evoluscend Mold Release_Final.pdf
PowerPoint Presentation
M E D I C A L C O N N E C T O R S
• Ongoing production with no change to regular set up
• Excellent processing and demolding performance
• Color stability during processing
• Excellent chemical and impact resistance
• Enabled efficient ongoing production rates without
changing any processing parameters
• Safeguarded color stability and transparency
during processing for optimal aesthetics
• Ensured regulatory requirements for
biocompatible ISO109931 and FDA were met
• Provided a solution effective across a range of
high-temperature polymers, including PEEK,
PPSU, PES, PSU, PEI, LCP, and PPS
Colorant Chromatics Evoluscend non-
PFAS* high-temperature polymer mold release
additive
KEY REQUIREMENTS WHY AVIENT
AVIENT SOLUTION
PRODUCTIVITY + REGULATORY
LEARN MORE
E L E C T R I C A L
C O M P O N E N T O E M
(*) A non-PFAS additive manufactured without non-intentionally added (NIA) PFAS or PTFE.
(*) manufactured without intentionally added PFAS and without PTFE
(1) refers to sulfone products only
https://www.avient.com/products/polymer-additives/processing-enhancement-additives/colorant-chromatics-evoluscend-non-pfas-high-temperature-mold-release-additive
Slide Number 1
https://www.avient.com/resources/safety-data-sheets?page=4265
203.63 ETFE200(2181) CC HIGH ORANGE
213.63 ETFE210(2185) CC HIGH ORANGE
832.63 KYNARFLEX CC DBL ORANGE
https://www.avient.com/resources/safety-data-sheets?page=6896
34550 EPIC RIVAL SPORT VICTORY ORANGE
32550 EPIC RIVAL SPORT VICTORY TN ORANGE
30550 EPIC RIVAL SPORT VICTORY TX ORANGE
https://www.avient.com/resources/safety-data-sheets?page=4570
2515LBFF APR EPIC TOP SCORE BRT ORANGE
2517LBFF APR EPIC TOP SCORE TEXAS ORANGE
380RX EPIC RIO MIX BLAZE ORANGE
https://www.avient.com/resources/safety-data-sheets?page=7038
XRU-2944 KYNAR2850 CC ORANGE FOR DIL
KYNAR460 CC DBL ORANGE
TPU TRANS ORANGE 144C
https://www.avient.com/resources/safety-data-sheets?page=6595
LIQUID COLOR ORANGE BONAFONT 487-30285-1
LIQUID COLOR ORANGE PASA 487-368-1
LIQUID COLOR ORANGE WQC-OR1176-1R
https://www.avient.com/resources/safety-data-sheets?page=5436
30600 EPIC TOP SCORE LC TEXAS ORANGE
30850 EPIC TOP SCORE LC BURNT ORANGE
30150 EPIC TOP SCORE LC LIGHT ORANGE
https://www.avient.com/resources/safety-data-sheets?page=4274
T669.3 FEP HF CC ULTRA ORANGE
T809.3 ETFE EP-506 CMPD PRECOL ORANGE
T817.3 ETFE210 CC HIGH ORANGE
https://www.avient.com/resources/safety-data-sheets?page=4307
100.93 FEP100 CC STD ORANGE
110.63 FEP5100 (HF) CC STD ORANGE
113.43 FEP5100 (HF) CC HIGH ORANGE